Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF+ T Lymphocytes-Reference-Cited by-同舟云学术

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF+ T Lymphocytes

Published:2017-05-09 Issue:2 Volume:53 Page:265-276
ISSN:1080-0549
Container-title:Clinical Reviews in Allergy & Immunology
language:en
Short-container-title:Clinic Rev Allerg Immunol

Author:

Bystrom Jonas,Clanchy Felix I.,Taher Taher E.,Al-Bogami Mohammed M.,Muhammad Hawzheen A.,Alzabin Saba,Mangat Pamela,Jawad Ali S.,Williams Richard O.,Mageed Rizgar A.^ORCID

Funder

Pfizer UK

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s12016-017-8610-y/fulltext.html

Reference56 articles.

1. McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219

2. Suzuki A, Kochi Y, Okada Y, Yamamoto K (2011) Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis. FEBS Lett 585(23):3627–3632

3. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36(12):1681–1690

4. Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B (2008) Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372(9636):375–382

5. Klarenbeek NB, Allaart CF, Kerstens PJ, Huizinga TW, Dijkmans BA (2009) The BeSt story: on strategy trials in rheumatoid arthritis. Curr Opin Rheumatol 21(3):291–298

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Cytokines for the Prediction of the Effectiveness of TNFα Inhibitors Etanercept, Infliximab, and Adalimumab in the Treatment of Psoriasis;Journal of Clinical Medicine;2024-07-02

2. GMCSF: More an Inflammatory Immune ‘Cytokine’ Than a Growth Factor;Indian Journal of Rheumatology;2024-06-23

3. Contribution of adaptive immunity to human COPD and experimental models of emphysema;Physiological Reviews;2023-04-01

4. Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy;Journal of Clinical Medicine;2023-02-17

5. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis;Frontiers in Immunology;2023-02-13